Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 444, 552-553 (30 November 2006) | doi:10.1038/nature05406; Published online 15 November 2006
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Head of Production Biopharmaceuticals
- Rhein Minapharm Biogenetics
- Cairo (Egypt)
Gastroenterologist
- Gastrointestinal Diseases Inc.
- Georgia, USA
Stem-cell biology: A move in the right direction
Jeffrey S. Chamberlain1
Abstract
Stem-cell therapy is valued for its potential to restore damaged or degenerating tissues. Stem cells are now regularly used to renew blood, and it looks as if the next success could be in treating dystrophic muscle.
The potential of stem-cell technologies to revolutionize medical care is causing great excitement among biologists and the general public. Recent studies on embryonic and adult stem cells, coupled with advances in our understanding of how they can be coaxed into forming particular cell types and tissues, have improved the prospects for addressing a host of untreatable diseases.
- Jeffrey S. Chamberlain is in the Department of Neurology, University of Washington, Seattle, Washington 98195-7720, USA.
Email: jsc5@u.washington.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Research HighlightsNature Biotechnology News and Views (01 Dec 2006)
Shrinking genes for therapyNature Medicine News and Views (01 Mar 2002)
See all 3 matches for News And ViewsRESEARCH
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogsNature Article (30 Nov 2006)
PlGF?MMP-9?expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscleNature Medicine Letter (01 Sep 2008)
See all 43 matches for Research